Showing results (131-140 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 25, 2020
An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disabilityJerry S Wolinsky, Natalie J Engmann, Jinglan Pei, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 25, 2020
Treatment of multiple sclerosis in special populations: The case of refugeesMaya M Zeineddine, Bassem I Yamout
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 25, 2020
Factors affecting MS patients' health-related quality of life and measurement challenges in Lebanon and the MENA regionNatali Farran, Batoul R Safieddine, Mariam Bayram, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 5, 2020
Cannabinoid use among Americans with MS: Current trends and gaps in knowledgeTiffany J Braley, Daniel Whibley, Kevin N Alschuler, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2021
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patientsZygj van Lierop, A A Toorop, Eme Coerver, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 21, 2022
Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody diseaseDimitrios C Ladakis, Jennifer Gould, Jenny M Khazen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 21, 2022
Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT studySibyl Wray, Francois Jacques, Tamara A Miller, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 6, 2022
Association of multiple sclerosis with risk of mortality among a nationally representative sample of adults in the United StatesTyler J Titcomb, Wei Bao, Yang Du, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 9, 2021
COVID-19 vaccination willingness among people with multiple sclerosisXinran M Xiang, Chris Hollen, Qian Yang, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosisAlison M Luckey, Tim Anderson, Michael H Silverman, et al.
Pageof 61